UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms

BMC cancer, 2019-02, Vol.19 (1), p.184-9, Article 184

2019

Volltextzugriff (PDF)

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

Blood cancer journal (New York), 2018-02, Vol.8 (2), p.15-11, Article 15

2018

Volltextzugriff (PDF)

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Leukemia, 2021-02, Vol.35 (2), p.485-493

2021

Volltextzugriff (PDF)

Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey

BMC cancer, 2016-02, Vol.16 (167), p.167-167, Article 167

2016

Volltextzugriff (PDF)

Myeloproliferative Neoplasms: A Contemporary Review

JAMA oncology, 2015-04, Vol.1 (1), p.97

2015

Volltextzugriff (PDF)

Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms

Leukemia, 2021-04, Vol.35 (4), p.935-955

2021

Volltextzugriff (PDF)

JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response

Cancer discovery, 2015-03, Vol.5 (3), p.316-331

2015

Volltextzugriff (PDF)

Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms

Leukemia, 2020-04, Vol.34 (4), p.1062-1074

2020

Volltextzugriff (PDF)

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

Leukemia, 2010-06, Vol.24 (6), p.1128-1138

TEFFERI, A

2010

Volltextzugriff (PDF)

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

Leukemia, 2014-07, Vol.28 (7), p.1407-1413

2014

Volltextzugriff (PDF)

CHIPing Away at Proteomics to Find Correlations with Myeloid Neoplasms

Clinical cancer research, 2024-08, Vol.30 (15), p.3095-3097

2024

Volltextzugriff (PDF)

Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation

Cancer discovery, 2019-09, Vol.9 (9), p.1228-1247

2019

Volltextzugriff (PDF)

Direct and indirect costs for patients with myeloproliferative neoplasms

Leukemia & lymphoma, 2024-08, Vol.65 (8), p.1153-1160

2024

Volltextzugriff (PDF)

Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada

Leukemia & lymphoma, 2020-07, Vol.61 (8), p.1908-1919

2020

Volltextzugriff (PDF)

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4098-4103

2012

Volltextzugriff (PDF)

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

Leukemia, 2014-09, Vol.28 (9), p.1811-1818

2014

Volltextzugriff (PDF)

Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance

Clinical cancer research, 2013-04, Vol.19 (8), p.1933-1940

2013

Volltextzugriff (PDF)

Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders

Leukemia, 2024-06, Vol.38 (6), p.1266-1274

2024

Volltextzugriff (PDF)

Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation

Cancer discovery, 2016-04, Vol.6 (4), p.368-381

2016

Volltextzugriff (PDF)

Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2

Leukemia, 2022-01, Vol.36 (1), p.210-220

2022

Volltextzugriff (PDF)

JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling

Stem cells (Dayton, Ohio), 2018-11, Vol.36 (11), p.1676-1684

2018

Volltextzugriff (PDF)

Distinct effects of ruxolitinib and interferon-alpha on murine JAK2V617F myeloproliferative neoplasm hematopoietic stem cell populations

Leukemia, 2020-04, Vol.34 (4), p.1075-1089

2020

Volltextzugriff (PDF)

The psychological needs of adolescents and young adults with a diagnosis of myeloproliferative neoplasms: a systematic scoping review of the literature

Leukemia & lymphoma, 2024-05, Vol.65 (5), p.679-683

2024

Volltextzugriff (PDF)

1 – 25 von 1.869

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.707)

Publikationsform

Sprache

Englisch
(1.863)
Französisch
(6)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.846)
Life Sciences & Biomedicine
(1.829)
Humans
(1.692)
Hematology
(1.223)
Myeloproliferative Disorders - Genetics
(875)
Female
(653)
Male
(652)
Mutation
(607)
Middle Aged
(508)
Aged
(475)
Adult
(428)
Myeloproliferative Disorders
(423)
Myeloproliferative Disorders - Pathology
(383)
Leukemia
(369)
Tumors
(366)
Janus Kinase 2 - Genetics
(354)
Biological And Medical Sciences
(328)
Medical Sciences
(320)
Myeloproliferative Disorders - Diagnosis
(306)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.773)
Journals@Ovid
(893)
Free E-Journal (出版社公開部分のみ）
(855)
Ingenta.com
(799)
Nature
(451)
Nexis Uni
(421)
ScienceDirect
(389)
IngentaConnect Journals
(335)
Springer Online Journals
(291)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(250)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(248)
Taylor & Francis Journals Auto-Holdings Collection
(203)
Taylor & Francis
(200)
Taylor & Francis E-Journals
(188)
Publisher or Other Site
(187)
Wiley Online Library
(186)
Wiley Online Library Full Collection 2018
(154)
SpringerLink Series
(70)
Oxford Journals
(24)
Oxford Journals 2020 Medicine
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey

Myeloproliferative Neoplasms: A Contemporary Review

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms

JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response

Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms

CHIPing Away at Proteomics to Find Correlations with Myeloid Neoplasms

Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation

Direct and indirect costs for patients with myeloproliferative neoplasms

Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation

Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance

Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders

Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation

Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2

JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling

Distinct effects of ruxolitinib and interferon-alpha on murine JAK2V617F myeloproliferative neoplasm hematopoietic stem cell populations

The psychological needs of adolescents and young adults with a diagnosis of myeloproliferative neoplasms: a systematic scoping review of the literature

Aktive Filter

Suchergebnisse filtern